Table 1.
Studies Depicting the Outcomes of Endoscopic Management of Combined Biliary and Duodenal Obstruction
| Study | Number of patients | Type of strictures I/II/III | Technical success | Median stent patency | Survival | Re-intervention |
|---|---|---|---|---|---|---|
| Kaw et al. (2003) [13] | 18 | - | 94.4% | - | 78 days | 23.5 (11.7% each) |
| Maire et al. (2006) [14] | 100 (23 combined obstruction) | - | 91% | - | 11 mo | 22% (biliary) |
| Mutignani et al. (2007) [3] | 64 | 31/25/8 | 97% | - | 81 days (range, 2–447 days) | 19% |
| Moon et al. (2009) [19] | 8 | 3/5/0 | 87.5% | - | 91 days | - |
| Katsinelos et al. (2010) [12] | 39 | sequential/simultaneous 25/7 | 82.1% | D-9 mo | 9 mo | 28.1% (15.6%-duodenal, 12.5% biliary) |
| B-3 mo | ||||||
| Tonozuka et al. (2013) [23] | 11 (EUS-BD 8, ERCP-BD 3) | 1/10/0 | 100% | D-73.5±69.7 days | 76.5±67.8 days | D=0 |
| B-62.6±60.4 days | B=18.2% | |||||
| Canena et al. (2014) [24] | 50 | 35/11/4 | 100% | D-34 weeks | 18 weeks | 40% |
| B-27 weeks | ||||||
| Khashab et al. (2014) [25] | 38 (previous duodenal stent in place) | 6/19/2 (unclassified 11) | 34.2% | 8 patients died: 151 days (35-530) | - | 8.3% (biliary) |
| 3 patients alive: 64 days (33-121) | ||||||
| Hamada et al. (2018) [2] | 110 | 45/46/19 | - | B-450 days | - | - |
| ERCP-90 | D-617 days | |||||
| EUS BD-20 | ||||||
| Staub et al. (2018) [10] | 71 (previous duodenal stent in place) | 46/21/4 | 85% | - | 4.6 mo (mean) | - |
| 87%/76%/100% |
D, duodenal; B, biliary; EUS-BD, endoscopic ultrasound-guided biliary drainage; ERCP, endoscopic retrograde cholangiopancreaticography.